TY  - GEN
AU  - Flisiak,Robert
AU  - Flisiak-Jackiewicz,Marta
TI  - Ombitasvir and paritaprevir boosted with ritonavir and combined with dasabuvir for chronic hepatitis C
SN  - 1747-4132
PY  - 2018///0319
KW  - 2-Naphthylamine
KW  - Administration, Oral
KW  - Anilides
KW  - administration & dosage
KW  - Antiviral Agents
KW  - Carbamates
KW  - Cyclopropanes
KW  - Drug Combinations
KW  - Drug Interactions
KW  - Drug Resistance, Viral
KW  - Drug Therapy, Combination
KW  - Genotype
KW  - Hepacivirus
KW  - drug effects
KW  - Hepatitis C, Chronic
KW  - diagnosis
KW  - Humans
KW  - Lactams, Macrocyclic
KW  - Macrocyclic Compounds
KW  - Proline
KW  - analogs & derivatives
KW  - Ritonavir
KW  - Sulfonamides
KW  - adverse effects
KW  - Sustained Virologic Response
KW  - Treatment Outcome
KW  - Uracil
KW  - Valine
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1080/17474124.2017.1309284
ER  -